Literature DB >> 9725707

Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems.

K Ikeda1, M Watanabe, T Ichikawa, T Kobayashi, R Yano, T Kumanishi.   

Abstract

Nociceptin/orphanin FQ (N/OFQ) and its receptor share similarities to opioids and their receptors in terms of the molecular structure and signaling pathway, but the two systems exhibit different actions in vivo. To understand the mechanism of N/OFQ-system actions, we examined, by in situ hybridization analysis, the distribution of preproN/OFQ and N/OFQ receptor mRNAs in the developing and adult mouse central nervous systems (CNS). In most neural regions, preproN/OFQ mRNA was mainly expressed in a small population of middle-sized neurons. These neurons were scattered between large projection-type neurons or within the neuropil, suggestive of interneurons. In some other nuclei (lateral septum, bed nucleus of the stria terminalis, reticular thalamic nucleus, inferior colliculus, and rostral periolivery nucleus), preproN/OFQ mRNA was expressed in a number of large projection-type neurons. By contrast, N/OFQ receptor mRNA was evenly expressed in most neurons of the adult CNS. Considering the inhibitory actions of N/OFQ, the distinct cellular expression pattern of the N/OFQ system suggests that the release of N/OFQ from interneurons may lower neuronal and synaptic activities of neighboring neurons, leading to integration or modulation of local circuits. Furthermore, the cellular expression pattern, distinct from that of the opioid system, may provide a possible molecular/cellular basis for the different in vivo actions of N/OFQ and opioids. In embryonic stages, both preproN/OFQ and N/OFQ receptor mRNAs were highly and widely expressed in the mantle zone, suggesting the possible importance of N/OFQ signaling in CNS development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725707     DOI: 10.1002/(sici)1096-9861(19980914)399:1<139::aid-cne11>3.0.co;2-c

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  24 in total

1.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.

Authors:  Yanning Hou; Mariana M Belcheva; Amy L Clark; Daniel S Zahm; Carmine J Coscia
Journal:  Neurosci Lett       Date:  2005-11-21       Impact factor: 3.046

3.  Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus.

Authors:  Susanne Meis; Thomas Munsch; Hans-Christian Pape
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 4.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

6.  The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

Authors:  K Ikeda; T Kobayashi; T Ichikawa; T Kumanishi; H Niki; R Yano
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

7.  Central Amygdala Prepronociceptin-Expressing Neurons Mediate Palatable Food Consumption and Reward.

Authors:  J Andrew Hardaway; Lindsay R Halladay; Christopher M Mazzone; Dipanwita Pati; Daniel W Bloodgood; Michelle Kim; Jennifer Jensen; Jeffrey F DiBerto; Kristen M Boyt; Ami Shiddapur; Ava Erfani; Olivia J Hon; Sofia Neira; Christina M Stanhope; Jonathan A Sugam; Michael P Saddoris; Greg Tipton; Zoe McElligott; Thomas C Jhou; Garret D Stuber; Michael R Bruchas; Cynthia M Bulik; Andrew Holmes; Thomas L Kash
Journal:  Neuron       Date:  2019-04-24       Impact factor: 17.173

8.  Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala.

Authors:  Marisa Roberto; George R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

9.  Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.

Authors:  Logan C Meyer; Caitlin E Paisley; Esraa Mohamed; John W Bigbee; Tomasz Kordula; Hope Richard; Kabirullah Lutfy; Carmen Sato-Bigbee
Journal:  Glia       Date:  2017-09-14       Impact factor: 7.452

10.  The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.

Authors:  Roberto Ciccocioppo; Amalia Fedeli; Daina Economidou; Federica Policani; Friedbert Weiss; Maurizio Massi
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.